The Mitochondrial Disease Biobank was established at Mayo Clinic in 2009. Its mission is to collect blood and tissue samples from patients with known or suspected mitochondrial diseases and their family members, with the aim of advancing research that leads to improved medical care for people with mitochondrial disorders.
The Mitochondrial Disease Biobank provides researchers from Mayo Clinic and other institutions with mitochondrial disease specimens and statistical information. Knowledge gleaned from examining donated samples or reviewing biobank information is shared among investigators to advance research through collaboration.
Participants are a critical part of mitochondrial disease research. Although individual participants may not benefit directly, samples play a key role in better understanding mitochondrial disease and developing new treatments.
Potential biobank participants may be identified by a Mayo Clinic care provider or by a Mayo Clinic Biochemical Genetics Laboratory staff member if a clinical sample is sent in for testing. Or individuals may volunteer to participate without any prior contact with Mayo Clinic.
Biobank enrollees are asked to provide a blood sample or grant access to existing samples. The biobank stores the samples until a request from a researcher is received. Researchers are carefully screened before sharing samples, which may be used for research on anything from preventive measures to diagnosis and treatment.
The Mitochondrial Disease Biobank is funded by a generous private donation.